Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 6Stomach Neoplasms 1Resectable Pancreatic Cancer 1Neoplasms, Basal Cell 1Locally Advanced Unresectable or Metastatic Solid Tumors 1Localized Pancreatic Adenocarcinoma 1Gastroesophageal Adenocarcinoma 1Colorectal Cancer Metastatic 1Biliary Tract Neoplasms 1Ampullary Adenocarcinoma 1

Interventions

Bevacizumab 7Cetuximab 3Oxaliplatin 2Fluorouracil 2Capecitabine 2trifluridine tipiracil drug combination 1sintilimab 1irinotecan sucrosofate 1folfirinox 1balstilimab 1anisodamine 1Vemurafenib 1Sirtuins 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Liver Transplantation 1Leucovorin 1Irinotecan 1HMPL-013 1Folfox protocol 1Doxorubicin 1Dexamethasone 12-(phenylmethyl)-1-naphthol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Colorectal Cancer Metastatic × folfirinox × Clear all
NCT07193862 2026-02-27

Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis

Northwell Health

Phase EARLY_PHASE1 Recruiting
10 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡